Abstract:Protein-protein interactions of c-Myc (MYC) are often regulated by post-translational modifications (PTMs), such as phosphorylation, and crosstalk thereof. Studying these interactions requires proteins with unique PTM patterns, which are challenging to obtain by recombinant methods. Standard peptide synthesis and native chemical ligation can produce such modified proteins, but are time-consuming and therefore typically limited to the study of individual PTMs. Herein, we report the development of flow-based methods for the rapid synthesis of phosphorylated MYC sequences (up to 84 AA), and demonstrate the versatility of this approach for the incorporation of other PTMs (Nε methylation, sulfation, acetylation, glycosylation) and combinations thereof. Peptides containing up to seven PTMs and five phosphorylations were successfully prepared and isolated in high yield and purity. Our methodology was then applied in the production of ten PTM-decorated analogues of the MYC Transactivation Domain (TAD) to screen for binding to the tumor suppressor protein, Bin1, using heteronuclear NMR and native mass spectrometry. We determined the effects of phosphorylation and glycosylation on the strength of the MYC:Bin1 interaction, and reveal an influence of MYC sequence length on binding. Our platform for the rapid synthesis of MYC sequences up to 84 AA with distinct PTM patterns thereby enables the systematic study of PTM function at a molecular level, and offers a convenient way for an expedited screening of constructs.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop a fast and efficient method for synthesizing peptides and proteins containing multiple post - translational modifications (PTMs), especially multi - phosphorylation and other PTM modifications in the MYC transcriptional activation domain (TAD). Specifically, the authors aim to: 1. **Overcome the limitations of existing methods**: Traditional recombinant expression and enzymatic modification methods are difficult to precisely control the PTM pattern at specific positions, while standard peptide synthesis and native chemical ligation can be achieved but are time - consuming and have a low yield. Therefore, it becomes very challenging to study these complex PTM patterns and their impact on protein - protein interactions (PPIs). 2. **Develop a rapid synthesis method**: By optimizing the conditions of automated fast - flow peptide synthesis (AFPS), multiple phosphorylation sites and other PTMs (such as methylation, acetylation, sulfation, and glycosylation) can be efficiently introduced, thereby preparing modified peptides and proteins with high purity and high yield. 3. **Systematically study PTM functions**: Using the newly developed synthesis platform, a series of MYC TAD analogs containing different PTM patterns are prepared, and the effects of these modifications on the interaction between MYC and the tumor - suppressor protein Bin1 are studied by techniques such as nuclear magnetic resonance (NMR) and native mass spectrometry (native MS). This helps to reveal the specific role of PTM in regulating MYC function, especially the effects of phosphorylation and glycosylation on the MYC:Bin1 interaction strength and binding sites. 4. **Explore the influence of sequence length**: In addition to PTM, the influence of the length of MYC fragments on their interaction with Bin1 is also explored. Studies have shown that longer MYC fragments (such as MYC[1 - 84]) may contain additional Bin1 - binding sites, which behave differently from shorter fragments (such as MYC[55 - 68]). In summary, the core objective of this paper is to establish a general and efficient chemical synthesis platform, enabling scientists to more conveniently prepare complex - modified peptides and proteins, and further understand the molecular mechanisms of PTM in regulating biological processes.

Rapid Flow-Based Synthesis of Post-Translationally Modified Peptides and Proteins: A Case Study on MYC’s Transactivation Domain

Rapid Flow-Based Synthesis of Post-Translationally Modified Peptides and Proteins: A Case Study on MYC's Transactivation Domain

Investigation of Protein Post-Translational Modifications with Site-Specifically Incorporated Non-Canonical Amino Acids

Development of cell-free platforms for discovering, characterizing, and engineering post-translational modifications

Parallel Automated Flow Synthesis of Covalent Protein Complexes That Can Inhibit MYC-Driven Transcription

Rapid Production of Native and Mirror-Image Tumor Necrosis Factor-α through the Synergy of Automated Flow Peptide Synthesis and Native Chemical Ligation

Automated Flow Peptide Synthesis Enables Engineering of Proteins with Stabilized Transient Binding Pockets

A Versatile Method for Site-Specific Chemical Installation of Aromatic Posttranslational Modification Analogs into Proteins

Merging Flow Synthesis and Enzymatic Maturation to Expand the Chemical Space of Lasso Peptides

Post-translational modification-centric base editor screens to assess phosphorylation site functionality in high throughput

Development of DuoMYC: a synthetic cell penetrant miniprotein that efficiently inhibits the oncogenic transcription factor MYC

ProteomeTools: Systematic Characterization of 21 Post-translational Protein Modifications by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Using Synthetic Peptides*

Reversibly reactive affinity selection mass spectrometry enables maturation of covalent peptides

Chemical modification of proteins by insertion of synthetic peptides using tandem protein trans-splicing

Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors

Selective Activation of Peptide‐Thioester Precursors for Templated Native Chemical Ligations

Development and Applications of Chimera Platforms for Tyrosine Phosphorylation

Examining Myc-Dependent Translation Changes in Cellular Homeostasis and Cancer

Harmony of Protein Tags and Chimeric Molecules Empowers Targeted Protein Ubiquitination and Beyond

Exploring the dynamics and interactions of the N-myc transactivation domain through solution nuclear magnetic resonance spectroscopy